| Financial Year |
March 31 2023 |
| Monetary Funds |
636,235,642.13 |
| Held-for-trading Financial Assets |
33,528,000.00 |
| Notes Receivable |
1,760,000.00 |
| Accounts Receivable |
8,271,022.17 |
| Advances to Suppliers |
74,236,417.15 |
| Other Receivables |
21,689,242.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
694,108,035.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
100,602,660.95 |
| Other Current Assets |
976,943,948.30 |
| Total Current Assets |
2,547,374,969.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,468,402,794.41 |
| Investment Properties |
62,632,134.14 |
| Fixed Assetes |
1,013,851,152.01 |
| Under-construction Projects |
33,250,674.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
595,744.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
32,056,163.02 |
| Deferred Income Tax Assets |
6,801,793.41 |
| Other Non-Current Assets |
440,000.00 |
| Sub-Total of Non-Current Assets |
2,717,392,358.93 |
| Total Assets |
5,264,767,327.99 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
180,300,000.00 |
| Accounts Payable |
38,534,766.97 |
| Accounts Received In Advance |
15,095,105.38 |
| Employee Compensation Payable |
7,768,596.47 |
| Taxes Payable |
14,938,793.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
192,706,613.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,027,957.09 |
| Other Current Liabilities |
1,119,047.62 |
| Sub-Total of Current Liabilities |
473,871,832.87 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
552,488.01 |
| Deferred Income Tax Liabilities |
1,491,953.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,187,514.27 |
| Total Liabilities |
481,059,347.14 |
| Paid-In Capital(Or Share Stock) |
1,315,878,571.00 |
| Capital Surplus |
1,221,773,126.82 |
| Surplus Reserve |
262,280,250.76 |
| LESS:Treasury Stock |
34,116,864.71 |
| Undistributed Profits |
1,785,901,833.00 |
| Minority Stockholder's Interest |
213,802,203.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,569,905,777.63 |
| Owner's Equity（Stockholder's Equity） |
4,783,707,980.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,264,767,327.99 |
